Frontiers in Cell and Developmental Biology (Nov 2021)

Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications

  • Di Chen,
  • Shuai Ping,
  • Yushuang Xu,
  • Mengmeng Wang,
  • Xin Jiang,
  • Lina Xiong,
  • Li Zhang,
  • Honglu Yu,
  • Zhifan Xiong

DOI
https://doi.org/10.3389/fcell.2021.732036
Journal volume & issue
Vol. 9

Abstract

Read online

Gastric cancer (GC) is one of the most lethal malignancies worldwide. However, the molecular mechanisms underlying gastric carcinogenesis remain largely unknown. Over the past decades, advances in RNA-sequencing techniques have greatly facilitated the identification of various non-coding RNAs (ncRNAs) in cancer cells, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs). Accumulating evidence has revealed that ncRNAs are essential regulators in GC occurrence and development. However, ncRNAs represent an emerging field of cancer research, and their complex functionality remains to be clarified. Considering the lack of viable biomarkers and therapeutic targets in GC, further studies should focus on elucidating the intricate relationships between ncRNAs and GC, which can be translated into clinical practice. In this review, we summarize recent research progress on how ncRNAs modulate the malignant hallmarks of GC, especially in tumor immune escape, drug resistance, and stemness. We also discuss the promising applications of ncRNAs as diagnostic biomarkers and therapeutic targets in GC, aiming to validate their practical value for clinical treatment.

Keywords